Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Intangibles (2021 - 2025)

AC Immune (ACIU) has disclosed Intangibles for 4 consecutive years, with $57.6 million as the latest value for Q4 2024.

  • On a quarterly basis, Intangibles rose 1.26% to $57.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was $57.6 million, a 1.26% increase, with the full-year FY2024 number at $57.6 million, up 2.52% from a year prior.
  • Intangibles was $57.6 million for Q4 2024 at AC Immune, up from $56.8 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $57.6 million in Q4 2024 to a low of $52.3 million in Q4 2022.
  • A 4-year average of $55.3 million and a median of $55.8 million in 2023 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: decreased 4.29% in 2022, then increased 8.61% in 2023.
  • AC Immune's Intangibles stood at $54.7 million in 2021, then dropped by 4.29% to $52.3 million in 2022, then rose by 8.61% to $56.8 million in 2023, then increased by 1.26% to $57.6 million in 2024.
  • Per Business Quant, the three most recent readings for ACIU's Intangibles are $57.6 million (Q4 2024), $56.8 million (Q4 2023), and $52.3 million (Q4 2022).